These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 14085248)

  • 1. MEASLES VACCINATION. I. SEROLOGIC RESPONSES TO AN INACTIVATED VACCINE.
    NORRBY E; LAGERCRANTZ R; GARD S; CARLSTROEM G
    Arch Gesamte Virusforsch; 1963 Aug; 13():548-58. PubMed ID: 14085248
    [No Abstract]   [Full Text] [Related]  

  • 2. MEASLES VACCINATION. II. ANTIBODY TITERS 8 TO 9 MONTHS AFTER VACCINATION WITH AN INACTIVATED VACCINE.
    NORRBY E; CARLSTROEM G; LAGERCRANTZ R; GARD S
    Acta Paediatr (Stockh); 1964 Nov; 53():533-40. PubMed ID: 14225879
    [No Abstract]   [Full Text] [Related]  

  • 3. MEASLES VACCINATION. IV. RESPONSES TO TWO DIFFERENT TYPES OF PREPARATIONS GIVEN AS A FOURTH DOSE OF VACCINE.
    NORRBY E; LAGERCRANTZ R; GARD S
    Br Med J; 1965 Mar; 1(5438):813-7. PubMed ID: 14258844
    [No Abstract]   [Full Text] [Related]  

  • 4. IMMUNIZATION WITH INACTIVATED MEASLES VIRUS VACCINE.
    GARD S; CARLSTROEM G; LAGERCRANTZ R; NORRBY E
    Arch Gesamte Virusforsch; 1965; 16():315-23. PubMed ID: 14322885
    [No Abstract]   [Full Text] [Related]  

  • 5. COMPARISON OF THE HEMAGGLUTINATION INHIBITION TEST FOR MEASLES WITH SEROLOGICAL TESTS AND ITS APPLICATION TO A FIELD TRIAL.
    KUNITA N; KITAWAKI T; FUNAHASHI S; TOYOSHIMA K
    Biken J; 1963 Jul; 6():45-56. PubMed ID: 14147705
    [No Abstract]   [Full Text] [Related]  

  • 6. [VIROLOGICAL AND CLINICAL OBSERVATIONS FOLLOWING ACTIVE MEASLES IMMUNIZATION].
    HAAS R; VIVELL O; GAEDECKE R; SIGNER E; SCHUMACHER H; BERTHOLD H
    Dtsch Med Wochenschr; 1965 Jan; 90():193-200. PubMed ID: 14240834
    [No Abstract]   [Full Text] [Related]  

  • 7. Measles vaccination. 3. Serologic responses to immunization with purified hemagglutinin.
    Norrby E; Lagercrantz R; Gard S; Carlström G
    Acta Paediatr Scand; 1965 Nov; 54(6):581-6. PubMed ID: 5832151
    [No Abstract]   [Full Text] [Related]  

  • 8. STUDIES ON IMMUNITY TO MEASLES.
    KRUGMAN S; GILES JP; FRIEDMAN H; STONE S
    J Pediatr; 1965 Mar; 66():471-88. PubMed ID: 14264306
    [No Abstract]   [Full Text] [Related]  

  • 9. Some characteristics of immunity following natural measles and various forms of immunization.
    Enders-Ruckle G
    Arch Gesamte Virusforsch; 1967; 22(1):23-34. PubMed ID: 5602131
    [No Abstract]   [Full Text] [Related]  

  • 10. [Anti-measles vaccination with the Schwarz hyperattenuated live vaccine; post-vaccinal virological study and serological examination for 2 years].
    Boué A; Celers J
    Pathol Biol; 1967 Jan; 15(1):65-70. PubMed ID: 5340408
    [No Abstract]   [Full Text] [Related]  

  • 11. KILLED MEASLES VACCINE PRIOR TO SEVEN MONTHS OF AGE FOLLOWED BY ATTENUATED LIVE VIRUS VACCINE AT NINE MONTHS.
    KARELITZ S; SCHLUEDERBERG A; KANCHANAVATEE P; ARAI M; ACS H
    Arch Gesamte Virusforsch; 1965; 16():343-6. PubMed ID: 14322891
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparative study of the immunogenic activity of 2 variants of the measles virus].
    Chiarini A; Brancato P; Sinatra A
    Riv Ist Sieroter Ital; 1968; 43(4):175-88. PubMed ID: 5747129
    [No Abstract]   [Full Text] [Related]  

  • 13. VACCINATION AGAINST MEASLES.
    ENDERS JF
    Aust J Exp Biol Med Sci; 1963 Aug; 41():SUPPL467-89. PubMed ID: 14058869
    [No Abstract]   [Full Text] [Related]  

  • 14. CLINICAL AND SEROLOGICAL OBSERVATIONS ON THE CHILDREN GIVEN ATTENUATED MEASLES VACCINE.
    ARAI M; NAKAMURA M; AKAMATSU T; KIMURA M; KITAYAMA T; KOIDE G
    Acta Paediatr Jpn; 1963 Dec; 14():9-16. PubMed ID: 14200614
    [No Abstract]   [Full Text] [Related]  

  • 15. SIMULTANEOUS ADMINISTRATION OF ORAL POLIO VACCINE AND GLOBULIN-MODIFIED ATTENUATED MEASLES-VIRUS VACCINE.
    FROESCHLE JE; CASEY H
    J Pediatr; 1965 Jun; 66():1031-4. PubMed ID: 14288455
    [No Abstract]   [Full Text] [Related]  

  • 16. OBSERVATIONS ON THE FURTHER ATTENUATION OF MEASLES VIRUS AND ON LIVE VACCINES PREPARED FROM HIGHLY ATTENUATED LINES OF VIRUS.
    CHU CM; KU YF; CHANG YH
    Chin Med J; 1964 Aug; 83():483-96. PubMed ID: 14174535
    [No Abstract]   [Full Text] [Related]  

  • 17. Durability of antibodies induced by inactivated measles virus vaccine.
    Masuno S; Kaneko T; Arakawa S
    Zentralbl Bakteriol Orig; 1968 Apr; 206(3):353-60. PubMed ID: 5707315
    [No Abstract]   [Full Text] [Related]  

  • 18. [Evaluation of the vaccination of a misture of inactivated and live measles vaccines. 1. Clinicoserological observation for a period of 4 years].
    Tanaka H
    Nihon Shonika Gakkai Zasshi; 1972 Mar; 76(3):162-9. PubMed ID: 5065657
    [No Abstract]   [Full Text] [Related]  

  • 19. A comparative study on antigenicity of live and inactivated measles vaccine.
    Arakawa S; Kaneko T
    Jpn J Exp Med; 1966 Feb; 36(1):37-47. PubMed ID: 5297255
    [No Abstract]   [Full Text] [Related]  

  • 20. A serological study of children vaccinated against measles.
    Strauss J; Zdrazílek J; Svandová E; Sejda J; Helcl J
    J Hyg Epidemiol Microbiol Immunol; 1969; 13(4):468-81. PubMed ID: 5391988
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.